VANCOUVER, BC — Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced today the closing of an oversubscribed U.S. $85 million Series… Read More
Chris Procyshyn kept hearing a common refrain when he began talking to potential customers about the robotic machines his B.C. company was developing. “‘It sounds too good to be true,’”… Read More
James Priour promoted to Chief Commercial Officer, added to Zymeworks’ Executive Committee John Babcook recognized as Distinguished Fellow VANCOUVER, BC – Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing… Read More
The Michael Smith Foundation for Health Research (MSFHR) and the BC Academic Health Science Network (BC AHSN) have signed a Memorandum of Understanding to join forces to create a dynamic… Read More
Industry innovator developing products based on established, pharmaceutical-grade health supplement ingredients and genomics, announces funding supporting R&D project for immune system analysis. VANCOUVER, BC – ImmunoFlex™, a life sciences company developing… Read More
